Assertio Therapeutics Mergers and Acquisitions Summary

Life Science Company

Assertio Therapeutics has acquired 2 companies, including 1 in the last 5 years. It has also divested 3 assets.

Assertio Therapeutics’ largest acquisition to date was in 2013, when it acquired Nautilus Neurosciences - CAMBIA® for $49M. It’s largest disclosed sale occurred in 2020, when it sold Assertio Therapeutics - NUCYNTA to Collegium Pharmaceutical for $375M. Assertio Therapeutics has acquired in 2 different US states. The Company’s most targeted sectors include life science (50%) and medical products (50%).

Join Mergr and gain access to Assertio Therapeutics’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity2
    • M&A Sell Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 4
  • M&A Advisors 3

Assertio Therapeutics, Inc.

100 South Saunders Road Suite 300,
Newark, California 60045
United States,
(224) 419-7106
www.assertiotx.com

Assertio Therapeutics, Inc. is a pharmaceutical company focused on products to treat pain and other central nervous system (CNS) conditions. Assertio Therapeutics was founded in 1995 and is based in Lake Forest, Illinois.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.2/yr) # 1 - - - - 1 2
vol $49M $49M
Sell (0.4/yr) # 1 - - - - 2 3
vol $503M $503M
  5

Most Recent M&A

Company Date Value Type
Zyla Life Sciences 2020-03-16 - Merger
Wayne, Pennsylvania · www.zyla.com
Assertio Therapeutics, Inc. - NUCYNTA 2020-02-06 375M USD Divestiture
, California
Assertio Therapeutics, Inc. - Gralise Business 2020-01-13 128M USD Divestiture
Newark, California
Depomed - Diabetes Royalty Rights 2015-11-04 - Divestiture
, United States
Nautilus Neurosciences - CAMBIA® (Diclofenac Potassium for Oral Solution) 2013-12-17 49M USD Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (50%) - 2 (67%) 503M (100%)
Medical Products 1 (50%) 49M (100%) 1 (33%) -
Total 2 $49M 3 $503M

By Geo

State/Country Buy Value Sell Value
United States 2 49M 3 503M
  California - - 2 503M
  Pennsylvania 1 - - -
Total 2 $49M 3 $503M

Top M&A Advisors

Financial Deals
Stifel, Nicolaus & Co., Inc.
2
Legal Deals
Gibson, Dunn & Crutcher LLP
2
Greenberg Traurig LLP
1

Deal Values

buy # Total
< $100M 1 $49M
TOTAL $49M
Largest Nautilus Neurosciences - CAMBIA® (Diclofenac Potassium for Oral Solution)
$49M (2013-12-17)
sell # Total
$100M to $1B 2 $503M
TOTAL $503M
Largest Assertio Therapeutics, Inc. - NUCYNTA
$375M (2020-02-06)

M&A Connections

Deals %
Acquired from
Strategic(s)
100%
1 100%
Divested to
Strategic(s)
100%
3 100%

 Subscribe to unlock this and 150,339
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.9K Private Equity Firms
  • 138K M&A Transactions
  • 146K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 39K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.